Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.9K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.4K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.7K
Stem Cell Culture01:17

Stem Cell Culture

6.6K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.6K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

4.0K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human stem cell-derived GABAergic interneuron development reveals early emergence of subtype diversity and gradual electrochemical maturation.

Neuron·2025
Same author

Human pallial MGE-type GABAergic interneuron cell therapy for chronic focal epilepsy.

Cell stem cell·2023
Same author

A stem cell journey in ophthalmology: From the bench to the clinic.

Stem cells translational medicine·2021
Same author

CIRM tools and technologies: Breaking bottlenecks to the development of stem cell therapies.

Stem cells translational medicine·2020
Same author

Proceedings: Using Stem Cell Therapies to Reestablish Osteogenic Capability for Bone Regeneration.

Stem cells translational medicine·2015
Same author

Proceedings: moving toward cell-based therapies for liver disease.

Stem cells translational medicine·2015

Related Experiment Video

Updated: Apr 7, 2026

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

12.5K

Proceedings: Moving Toward Cell-Based Therapies for Heart Disease.

Lila R Collins1, Catherine Priest2, Ingrid Caras2

  • 1California Institute for Regenerative Medicine, San Francisco, California, USA lcollins@cirm.ca.gov.

Stem Cells Translational Medicine
|July 3, 2015
PubMed
Summary

Cell-based therapies offer new hope for heart disease patients by potentially replacing lost tissue and reducing scar formation after myocardial infarction. Research is ongoing to optimize cell types, disease timing, and delivery methods for improved cardiac function.

More Related Videos

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

11.0K
Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing
11:09

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Published on: March 19, 2013

11.7K

Related Experiment Videos

Last Updated: Apr 7, 2026

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

12.5K
Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

11.0K
Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing
11:09

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Published on: March 19, 2013

11.7K

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Cell Therapy

Background:

  • Heart disease, particularly following myocardial infarction (MI) and subsequent heart failure, remains a significant unmet medical need.
  • Current treatments for MI do not prevent cardiac muscle loss or limit scar tissue formation, leading to impaired heart function.
  • Cell-based therapies are being explored to address these limitations by potentially regenerating cardiac tissue or providing beneficial paracrine factors.

Purpose of the Study:

  • To investigate the potential of cell-based therapies in treating heart disease after myocardial infarction.
  • To explore how cell therapies might replace lost cardiac muscle and reduce scar formation.
  • To identify optimal cell types, disease stages, and delivery methods for effective cardiac repair.

Main Methods:

  • Preclinical and clinical investigations of various cell-based therapeutic strategies.
  • Evaluation of cell therapy effects on cardiac muscle regeneration, inflammation, blood supply, cell survival, and scar size.
  • Supportive research funded by the California Institute for Regenerative Medicine.

Main Results:

  • Cell therapies show promise in addressing the underlying causes of heart dysfunction post-MI.
  • Potential benefits include tissue replacement, reduced inflammation, enhanced vascularization, improved cell survival, and decreased scar burden.
  • Ongoing research aims to clarify the most effective approaches for clinical application.

Conclusions:

  • Cell-based therapies represent a promising avenue for developing improved treatments for heart disease.
  • Further research is needed to determine the optimal parameters for cell therapy to maximize benefits for patients with heart failure.
  • Regenerative medicine approaches hold significant potential for advancing cardiovascular care.